Classes #16-#19: Interventional Study Designs Flashcards

1
Q

What type of study is required by the FDA in order to get consideration for approval of a new drug?

A

Interventional Study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some other common names for interventional study designs?

A
Clinical Trial
Clinical Study
Experimental Study
Human Study
Investigational Study

*NOT the only design for these terms for studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When comparing observational studies and interventional study design, what are the key differences of interventional studies?

A

> Investigator selects “interventions” and allocates study subjects to forced-intervention groups

> More “rigorous” in ability to show cause-and-effect
- can demonstrate CAUSATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the phases of interventional studies?

A

Pre-Clinical -> Phase 1 -> Phase 2 -> Phase 3 -> Phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bench and Animal research would be in which phase of interventional studies?

A

Pre-Clinical (prior-to human investigation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the primary focus of the researchers in phases 1 and 4 in an interventional study?

A

Safety

*remember that safety is always of concern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which phase of an interventional study would most likely be expected if the study was of short duration and had an N-value of 79?

A

Phase 1 (new drug/device/procedure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the primary focus of phases 2 and 3 in an interventional study design?

A

Primary focus is on effectiveness (efficacy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In a study that reaches phase 4 that is looking at a new drug, what change would you expect about the drug between phase 3 and 4?

A

The drug would not reach phase 4 without having a name. Thus, a named drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the average N-value in a phase 2 study and what is the expected duration of the study? Also, is restriction present in participants allowed to enter the study?

A

N-value = 100-300 people

Short-to-Medium Duration (a few to several months)

Yes, likely to have a narrower inclusion criteria for participants in study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What kind of patients are usually chosen for phase 2 studies?

A

Commonly utilize patients with condition of interest, used to expand on purpose of Phase 1 study (safety) but also to begin assessing efficacy in diseased population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

For a phase 3 study, what is the expected N-value, study duration, and typical patient selection criteria?

A

N (1,000-3,000)

Long duration (many months to a year (or few years))

Used in patients with condition of interest to continue determination of safety, with primary purpose to assess efficacy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In which phase of interventional study design does the FDA approve or not prove a drug of interest?

A

Phase 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Can a drug that’s in phase 3 of an interventional study be named?

A

Yes

*Dr. Segars said, “don’t get confused on the exam if I give you a study that has a named drug and think that it can’t be phase 3 and that it is only in phase 4”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Would an interventional study enter phase 4 after or before approval from the FDA?

A

After approval from the FDA.

*phase 4 (post-marketing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discus phase 4 of a study and why it is performed and sometimes mandated by the FDA?

A

Long-term effects (risks and benefits) in a large population of diseases patients (expanded use population (age, ethnic)).
- registries, survey’s (e.g., FDA’s MedWatch/FAERS/VAERS programs)

17
Q

What are 2 advantages of an interventional trial, versus other designs?

A

1) Cause precedes effect (shows Causation)

2) Only design used by FDA for “approval” process (on-label)

18
Q

What are a few of the disadvantages of interventional trials, versus other designs?

A
  1. cost
  2. complexity/time (development/approval/conductance)
  3. ethical considerations (risk vs. benefit evaluation)
  4. generalizability (a.k.a.; External Validity) - is study population similar to general population and will methodology and findings be applicable to them?
19
Q

What is the only type of study that can prove causation?

A

Interventional Study